identification of egfr mutations impact overall prognosis in lung cancers
Published 4 years ago • 422 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
20:34
2021 west oncology | lung cancer | egfr mutation therapy resistance and adcs and trop2
-
2:26
egfr mutations in nsclc
-
1:41
egfr mutations in patients with lung cancer
-
3:38
overview of the world of egfr mutant lung cancers
-
1:05:12
new horizons in egfr-mutated nsclc: broadening the impact of precision testing
-
1:24
egfr tkis excite treatment landscape of egfr-mutant lung cancers
-
0:48
current role of immunotherapy in egfr-mutant lung cancer
-
30:32
2023 best of lung: targeted therapies in lung cancer
-
1:04
ngs provides improved identification of uncommon egfr mutations over pcr in nsclc
-
5:34
rare egfr mutations in lung adenocarcinoma
-
1:01:27
molecular testing for egfr mutations: what pathologists need to know
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
3:41
how do doctors treat lung cancer with egfr mutations?
-
14:24
egfr-mutant lung cancer & treatment options | 2023 living with egfr-mutant lung cancer patient forum
-
3:14
advancements of targeted therapy for egfr mutations in nsclc
-
3:31
osimertinib plus gefitinib for treatment of egfr-mutated non-small cell lung cancer
-
1:00
uncommon egfr mutations in metastatic non-small cell lung cancer.
-
13:26
debate: drug of choice for exon 19 del egfr mutant nsclc - any egfr tki
-
5:02
egfr-mutant lung cancer: initial approach